valine has been researched along with probucol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuyama, M; Hashimoto, T; Hayasaka, K; Matsunaga, A; Ogino, D; Toyoda, K | 1 |
| Feng, Z; Hou, S; Hu, H; Liang, Y; Shi, W; Shi, X; Wang, L; Wang, W; Xia, Y; Xu, L; Yan, H; Ye, Z; Zhang, B; Zhang, L; Zhong, W | 1 |
1 trial(s) available for valine and probucol
| Article | Year |
|---|---|
Probucol combined with valsartan in immunoglobulin A nephropathy: a multi-centre, open labelled, randomized controlled study.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antioxidants; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Humans; Male; Middle Aged; Probucol; Tetrazoles; Valine; Valsartan | 2014 |
1 other study(ies) available for valine and probucol
| Article | Year |
|---|---|
Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy.
Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Apolipoproteins E; Bezafibrate; Child; Child, Preschool; Enalapril; Female; Hematuria; Humans; Hypolipidemic Agents; Kidney Diseases; Kidney Failure, Chronic; Kidney Glomerulus; Nephrotic Syndrome; Probucol; Tetrazoles; Valine; Valsartan | 2009 |